Earnings History Data for Viking Therapeutics, Inc. (VKTX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Viking Therapeutics, Inc.
Viking Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in development of novel therapies for metabolic and endocrine disorders. Its product candidate consists of VK5211, VK0214, VK0612 and VK2809 which are in different clinical trial. Viking Therapeutics, Inc. is based in LA JOLLA, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-02-2024 | AH | VKTX | Viking Therapeutics, Inc. | 2,470 | -0.25 | -0.25 | -0.26 | Viking Therapeutics GAAP EPS of -$0.25 beats by $0.01 [2/7/2024 4:09 PM] |
28.88 | 4.40 (17.97%) |
25.75 | 1.27 (5.19%) |
8.28 - 29.45 | 7,889,669 | 2,800,000 | 84,556 | ||
| 25-10-2023 | AH | VKTX | Viking Therapeutics, Inc. | 1,040 | -0.23 | -0.22 | -0.21 | Viking Therapeutics GAAP EPS of -$0.23 misses by $0.01 [10/25/2023 4:08 PM] |
9.62 | -1.05 (-9.84%) |
9.05 | -1.62 (-15.18%) |
3.54 - 25.72 | 4,355,184 | 2,400,000 | 60,127 | ||
| 26-07-2023 | AH | VKTX | Viking Therapeutics, Inc. | 1,440 | -0.19 | -0.21 | -0.23 | Viking Therapeutics GAAP EPS of -$0.19 in-line [7/26/2023 4:15 PM] |
13.71 | -0.57 (-4.03%) |
13.62 | -0.66 (-4.62%) |
2.53 - 25.72 | 2,162,272 | 1,560,000 | 14,630 | ||
| 26-04-2023 | AH | 4:05 PM ET (Apr 26) |
VKTX | Viking Therapeutics, Inc. | 2,100 | -0.25 | -0.24 | -0.21 | Viking Therapeutics GAAP EPS of -$0.25 misses by $0.01 [4/26/2023 4:08 PM] |
19.62 | 0.07 (0.38%) |
20.24 | 0.69 (3.53%) |
2.02 - 22.04 | 2,564,520 | 4,240,000 | 25,296 | |
| 08-02-2023 | AH | 4:05 PM ET (Feb 8) |
VKTX | Viking Therapeutics, Inc. | 697.87 | -0.26 | -0.23 | -0.16 | Viking Therapeutics GAAP EPS of -$0.26 misses by $0.03 [2/8/2023 4:22 PM] |
10.68 | 1.12 (11.66%) |
9.55 | -0.01 (-0.10%) |
2.02 - 11.08 | 4,360,097 | 1,590,000 | 6,410 | |
| 26-10-2022 | AH | 4:05 PM ET (Oct 26) |
VKTX | Viking Therapeutics, Inc. | 309.82 | -0.21 | -0.23 | -0.17 | Viking Therapeutics GAAP EPS of -$0.21 beats by $0.02 [10/26/2022 4:30 PM] |
4.06 | -0.09 (-2.17%) |
4.30 | 0.15 (3.61%) |
2.02 - 7.05 | 695,535 | 1,450,000 | 899 | |
| 27-07-2022 | AH | 4:10 PM ET (Jul 27) |
VKTX | Viking Therapeutics, Inc. | 261.52 | -0.23 | -0.21 | -0.20 | Viking Therapeutics GAAP EPS of -$0.23 misses by $0.02 [7/27/2022 4:33 PM] |
3.19 | 0.02 (0.47%) |
3.20 | 0.02 (0.63%) |
2.02 - 7.20 | 763,879 | 1,140,000 | 1,265 | |
| 27-04-2022 | AH | 4:05 PM ET (Apr 27) |
VKTX | Viking Therapeutics, Inc. | 190.34 | -0.21 | -0.20 | -0.19 | Viking Therapeutics GAAP EPS of -$0.21 misses by $0.02 [4/27/2022 4:11 PM] |
2.39 | 0.19 (8.64%) |
2.19 | -0.01 (-0.45%) |
2.15 - 7.20 | 873,981 | 1,010,000 | 1,179 | |
| 09-02-2022 | AH | 4:05 PM ET (Feb 9) |
VKTX | Viking Therapeutics, Inc. | 277.73 | -0.16 | -0.19 | -0.15 | Viking Therapeutics GAAP EPS of -$0.16 beats by $0.03 [2/9/2022 4:08 PM] |
4.05 | 0.32 (8.58%) |
3.80 | 0.07 (1.88%) |
3.21 - 9.41 | 1,887,904 | 1,180,000 | 12,084 | |
|
||||||||||||||||||
| 03-11-2021 | AH | 4:05 PM ET (Nov 3) |
VKTX | Viking Therapeutics, Inc. | 480.09 | -0.17 | -0.21 | -0.13 | Viking Therapeutics EPS beats by $0.04 [11/3/2021 4:10 PM] |
6.72 | 0.14 (2.13%) |
6.72 | 0.0 (0.00%) |
4.95 - 10.09 | 1,209,543 | 640,000 | 3,487 | |
|
||||||||||||||||||
| 28-07-2021 | AH | 4:05 PM ET (Jul 28) |
VKTX | Viking Therapeutics, Inc. | 439.70 | -0.20 | -0.19 | -0.13 | Viking Therapeutics EPS in-line [7/28/2021 4:12 PM] |
6.07 | 0.22 (3.67%) |
5.94 | 0.08 (1.37%) |
4.95 - 10.09 | 677,962 | 560,000 | 5,431 | |
|
||||||||||||||||||
| 28-04-2021 | AH | 4:05 PM ET (Apr 28) |
VKTX | Viking Therapeutics, Inc. | 486.22 | -0.19 | -0.18 | -0.13 | Viking Therapeutics EPS misses by $0.02 [4/28/2021 4:16 PM] |
6.26 | -0.10 (-1.57%) |
6.26 | 0.0 (0.00%) |
5.22 - 10.09 | 805,754 | 830,000 | 4,245 | |
|
||||||||||||||||||
| 17-02-2021 | AH | 4:05 PM ET (Feb 17) |
VKTX | Viking Therapeutics, Inc. | 612.07 | -0.15 | -0.15 | -0.10 | Viking Therapeutics EPS in-line [2/17/2021 4:10 PM] |
7.57 | -0.70 (-8.48%) |
8.30 | 0.03 (0.36%) |
3.26 - 10.09 | 1,475,439 | 2,279,494 | 16,440 | |
| 28-10-2020 | AH | 4:05 PM ET (Oct 28) |
VKTX | Viking Therapeutics, Inc. | 405.99 | -0.13 | -0.15 | -0.08 | Viking Therapeutics EPS beats by $0.02 [10/28/2020 4:15 PM] |
5.58 | 0.28 (5.28%) |
5.35 | 0.05 (0.94%) |
3.26 - 8.87 | 1,982,966 | 1,038,187 | 9,359 | |
|
|
||||||||||||||||||
| 29-07-2020 | AH | 4:05 PM ET (Jul 29) |
VKTX | Viking Therapeutics, Inc. | 504.55 | -0.13 | -0.14 | -0.11 | Viking Therapeutics EPS beats by $0.01 [7/29/2020 4:10 PM] |
7.51 | 0.90 (13.62%) |
6.70 | 0.09 (1.36%) |
3.26 - 8.87 | 1,859,823 | 915,608 | 17,851 | |
|
|
||||||||||||||||||